Multiple sclerosis Trials in New York, United States
Conditions / Multiple sclerosis / New York, United States
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
112 total trials for this combination
Showing top 10 of 112 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06141486 | Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis | RECRUITING | PHASE3 |
| NCT02047097 | Dimethyl Fumarate (DMF) Observational Study | COMPLETED | — |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT03387267 | Videofluoroscopic Swallowing Study (VFSS) | TERMINATED | NA |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT06203106 | NYSCF Scientific Discovery Biobank | RECRUITING | — |
| NCT05301335 | Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE CONTINENCE Clinical Study | COMPLETED | NA |
| NCT06136923 | An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer | COMPLETED | NA |
| NCT03222973 | Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) | TERMINATED | PHASE2 |